title: Successful treatment with infliximab for refractory pyoderma gangrenosum associated with inflammatory bowel disease.
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Hayashi
authors.forename: Chiaki
authors.initials: C
authors.lastname: Kuwabara
authors.forename: Kenichi
authors.initials: K
authors.lastname: Tarumi
authors.forename: Eiichi
authors.initials: E
authors.lastname: Makino
authors.forename: Wataru
authors.initials: W
authors.lastname: Fujimoto
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D016523:Foot Ulcer / Q000150:complications / Q000473:pathology / Q000628:therapy; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000150:complications*; D000069285:Infliximab; D008297:Male; D017511:Pyoderma Gangrenosum / Q000150:complications* / Q000473:pathology / Q000628:therapy*; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab